New-onset Atrial Fibrillation Predicts Heart Failure Progression

Slides:

Advertisements

Similar presentations

Atrial Fibrillation and Heart Failure Andrew A. Grace, MB, PhD, FRCP Heart Failure Clinics Volume 9, Issue 4, (October 2013) DOI: /j.hfc

Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Sexuality The American Journal of Medicine

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Discharge Heart Rate and Mortality after Acute Myocardial Infarction

An Unusual Cause of Leg Ulcerations

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Jeffrey H. Barsuk, MD, MS, Elaine R

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials Kenneth R. McQuaid, MD, Loren.

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Overview of Current Learning Theories for Medical Educators

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

Extreme Polyuria: At the Heart of the Answer

The Clinical Spectrum of Zika Virus in Returning Travelers

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

Osteoporotic Fractures and Heart Failure in the Community

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

Laura Boucai, MD, MS, William N

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

The Reply The American Journal of Medicine

TIA for the Internist The American Journal of Medicine

Gun Ownership and Firearm-related Deaths

Loop Diuretics for Heart Failure-associated Hyponatremia

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

An Enlarging Ulcer The American Journal of Medicine

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

Repeated Hemoglobin A1C Ordering in the VA Health System

Molly E. Waring, PhD, Jane S

Atrial Fibrillation and Heart Failure

The Malnourished Heart: An Unusual Case of Heart Failure

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Atrial Fibrillation and Heart Failure: It Takes Two to Tango

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

Purple Urinary Bag Syndrome

Devraj Sukul, MD, Shashank S. Sinha, MD, MSc, Andrew M

National Trends in Ambulatory Oral Anticoagulant Use

A Post-cure Complication

Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes John A. Dodson, MD, Tuyet-Trinh N. Truong,

Aorta–Aorta Fistula: Another Uncommon Cause of Heart Failure

The American Journal of Medicine

Plasma Lactescence in Acute Pancreatitis

Jeffrey H. Barsuk, MD, MS, Elaine R

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

Direct Observation of Residents: A Model for an Assessment System

Acquired Generalized Lipodystrophy Following Immune Thrombocytopenia

Falls in Older Adults: Risk Assessment, Management and Prevention

Has mortality from acute renal failure decreased

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Toward a More Responsible News Media

Exercise as a Therapeutic Intervention in Patients with Stable Ischemic Heart Disease: An Underfilled Prescription William E. Boden, MD, Barry Franklin,

Presentation transcript:

New-onset Atrial Fibrillation Predicts Heart Failure Progression Ryan G. Aleong, MD, William H. Sauer, MD, Gordon Davis, MS, Michael R. Bristow, MD, PhD The American Journal of Medicine Volume 127, Issue 10, Pages 963-971 (October 2014) DOI: 10.1016/j.amjmed.2014.06.006 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure Freedom from all-cause mortality by group: Group 1, new-onset atrial fibrillation, with follow-up beginning on the day of the event; Group 2, Atrial fibrillation (AF) free throughout the study; Baseline/chronic group, atrial fibrillation present at trial entry. BAF = baseline atrial fibrillation; NAF = new onset atrial fibrillation; HR = hazard ratio. The American Journal of Medicine 2014 127, 963-971DOI: (10.1016/j.amjmed.2014.06.006) Copyright © 2014 Elsevier Inc. Terms and Conditions